3‐phosphoglycerate dehydrogenase deficiency in a patient with West syndrome

  • Pineda M
  • Vilaseca M
  • Artuch R
  • et al.
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

3‐phosphoglycerate dehydrogenase deficiency is a severe but treatable disorder of serine synthesis, first described in 1996 (Jaeken et al. 1996a). The patient presented with West syndrome, severe psychomotor delay, failure to thrive, microcephaly, atypical ocular movements, and pyramidal signs. Treatment with oral L‐serine abolished seizures and improved psychomotor development, hyperexcitability, head growth, cortical and subcortical hypotrophy, and hypomyelination of the brain on MRI scans. 3–phosphoglycerate dehydrogenase deficiency is a treatable congential error that probably leads to West syndrome.

Cite

CITATION STYLE

APA

Pineda, M., Vilaseca, M. A., Artuch, R., Santos, S., González, M. G., Sau, I., … Jaeken, J. (2000). 3‐phosphoglycerate dehydrogenase deficiency in a patient with West syndrome. Developmental Medicine & Child Neurology, 42(9), 629–633. https://doi.org/10.1111/j.1469-8749.2000.tb00369.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free